论文信息 - 1212TiPPIVOT-02: A phase 1/2, open-label, multicenter, dose escalation and dose expansion study of NKTR-214 and nivolumab in patients with select, locally advanced or metastatic solid tumor malignancies - 字舞流文

1212TiPPIVOT-02: A phase 1/2, open-label, multicenter, dose escalation and dose expansion study of NKTR-214 and nivolumab in patients with select, locally advanced or metastatic solid tumor malignancies

M. Hurwitz | P. Hwu | M. Sznol | I. Puzanov | H. Kluger | D. Cho | B. Curti | N. Tannir | C. Haymaker | C. Bernatchez | S. Tykodi | A. Diab | M. Imperiale | S. Bentebibel | U. Hoch | S. Aung | I. Gergel | M. Wong | M. Tagliaferri | J. Zalevsky